N-Nitroso Nortriptyline D3 | N-Nitroso Amitriptyline EP Impurity C-D3
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. N-Nitroso Nortriptyline D3can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nitrosamines . N-Nitroso Nortriptyline D3 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nortriptyline D3 CAS NO:NA is also known as N-Nitroso Amitriptyline EP Impurity C-D3 Chemically represented as N-(3-(10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)propyl)-N-(methyl-d3)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Nortriptyline D3. We supply N-Nitroso Nortriptyline D3 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141826 |
| CAS No | NA |
| Mol.F. | C11H19N3O5 |
| Mol.Wt. | 273.29 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141827 |
| CAS No | NA |
| Mol.F. | C6H11N3O3 |
| Mol.Wt. | 173.17 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141828 |
| CAS No | NA |
| Mol.F. | C17H22N6O5 |
| Mol.Wt. | 390.40 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141829 |
| CAS No | NA |
| Mol.F. | C26H32ClN7O5 |
| Mol.Wt. | 558.04 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141830 |
| CAS No | NA |
| Mol.F. | C21H24ClN7O3 |
| Mol.Wt. | 457.92 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141831 |
| CAS No | NA |
| Mol.F. | C16H20N4O3S |
| Mol.Wt. | 348.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141832 |
| CAS No | NA |
| Mol.F. | C29H35N7O4S |
| Mol.Wt. | 577.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141833 |
| CAS No | NA |
| Mol.F. | C19H29N5O5S2 |
| Mol.Wt. | 471.6 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141834 |
| CAS No | NA |
| Mol.F. | C17H19N4O3S |
| Mol.Wt. | 359.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141835 |
| CAS No | NA |
| Mol.F. | C20H26N5O5S2 |
| Mol.Wt. | 480.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141836 |
| CAS No | NA |
| Mol.F. | C16H22N4O3S |
| Mol.Wt. | 350.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141837 |
| CAS No | NA |
| Mol.F. | C7H8N4O2 |
| Mol.Wt. | 180.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141838 |
| CAS No | NA |
| Mol.F. | C12H13N3O6 |
| Mol.Wt. | 295.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141839 |
| CAS No | NA |
| Mol.F. | C17H15N3O4 |
| Mol.Wt. | 325.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141840 |
| CAS No | NA |
| Mol.F. | C18H22N6O4 |
| Mol.Wt. | 386.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141841 |
| CAS No | NA |
| Mol.F. | C17H20N6O6 |
| Mol.Wt. | 404.4 |
| INV STATUS | CUSTOM SYNTHESIS |